Analysis: ViviGen Cellular Bone Matrix Lowers Hospital Costs vs. rhBMP-2

LifeNet Health ViviGen Matrices

Results of analysis of >16,000 U.S. lumbar fusions indicate that LifeNet Health's ViviGen® Cellular Bone Matrix was associated with significantly lower hospital costs compared to recombinant human bone morphogenetic protein-2 (rhBMP-2).

Specifically, the study showed that average charges associated with procedures using ViviGen were up...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0